Shanghai Shyndec Pharmaceutical Co Ltd
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers 6-APA, potassium clavulanate series, diclofenac sodium extended release tablets, urine-derived biochemical products, nifedipine controlled release tablets, azithromycin, ceftriaxone sodium for injection, methylprednisolone sodium succinate… Read more
Shanghai Shyndec Pharmaceutical Co Ltd (600420) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥486.04 Million) by net assets (CN¥15.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Shyndec Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Shanghai Shyndec Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Shyndec Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Shyndec Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orient Semiconductor Electronics Ltd
TW:2329
|
0.006x |
|
YaGuang Technology Group Co Ltd
SHE:300123
|
-0.035x |
|
HCI Group Inc
NYSE:HCI
|
0.031x |
|
Northking Information Technology Co
SHE:002987
|
0.027x |
|
Googol Technology Co Ltd Class A
SHE:301510
|
N/A |
|
Jingjin Environmental Protection Co Ltd
SHG:603279
|
0.049x |
|
AbClon Inc
KQ:174900
|
-0.075x |
|
Taiwan Secom Co Ltd
TW:9917
|
0.077x |
Annual Cash Flow Conversion Efficiency for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥15.32 Billion | CN¥2.26 Billion | 0.147x | +22.71% |
| 2023-12-31 | CN¥14.34 Billion | CN¥1.72 Billion | 0.120x | -48.94% |
| 2022-12-31 | CN¥12.15 Billion | CN¥2.86 Billion | 0.235x | +45.07% |
| 2021-12-31 | CN¥10.37 Billion | CN¥1.68 Billion | 0.162x | +1.94% |
| 2020-12-31 | CN¥9.82 Billion | CN¥1.56 Billion | 0.159x | +15.13% |
| 2019-12-31 | CN¥9.20 Billion | CN¥1.27 Billion | 0.138x | -30.19% |
| 2018-12-31 | CN¥8.44 Billion | CN¥1.67 Billion | 0.198x | -34.68% |
| 2017-12-31 | CN¥7.65 Billion | CN¥2.31 Billion | 0.303x | +150.41% |
| 2016-12-31 | CN¥6.94 Billion | CN¥838.58 Million | 0.121x | -14.06% |
| 2015-12-31 | CN¥1.61 Billion | CN¥226.65 Million | 0.141x | -24.27% |
| 2014-12-31 | CN¥1.39 Billion | CN¥258.51 Million | 0.186x | +18.60% |
| 2013-12-31 | CN¥1.33 Billion | CN¥207.50 Million | 0.157x | -3.62% |
| 2012-12-31 | CN¥1.19 Billion | CN¥193.41 Million | 0.162x | +13.10% |
| 2011-12-31 | CN¥947.63 Million | CN¥136.12 Million | 0.144x | +4.53% |
| 2010-12-31 | CN¥837.59 Million | CN¥115.11 Million | 0.137x | +0.63% |
| 2009-12-31 | CN¥713.46 Million | CN¥97.43 Million | 0.137x | +48.57% |
| 2008-12-31 | CN¥631.47 Million | CN¥58.04 Million | 0.092x | -33.63% |
| 2007-12-31 | CN¥594.29 Million | CN¥82.31 Million | 0.138x | -3.74% |
| 2006-12-31 | CN¥511.49 Million | CN¥73.60 Million | 0.144x | +19.00% |
| 2005-12-31 | CN¥478.84 Million | CN¥57.90 Million | 0.121x | +213.99% |
| 2004-12-31 | CN¥441.88 Million | CN¥17.02 Million | 0.039x | -- |